Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Witt

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Thrombolysis|July 6, 2019
Assessing patient preferences for switching from warfarin to direct oral anticoagulantsJack N Wright, Sara R Vazquez, Kibum Kim, et al.
Thrombosis Research|November 21, 2024
Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah HealthHailey L Vandenhazel, Aaron S Wilson, Xiangyang Ye, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
"Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies, among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world data": replyAmy L Kiskaddon, Ernest K Amankwah, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2023
A scoping review of direct oral anticoagulant ambulatory management practicesJasmine S Mangrum, John A Saunders, Nathorn Chaiyakunapruk, et al.
Journal of Thrombosis and Thrombolysis|January 4, 2011
Evaluation of venous thromboembolism risk following hospitalizationSheryl J Herner, Dwight C Paulson, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2005
A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapyKandace V Anich, Daniel M Witt, Thomas Delate, et al.
Chest|May 13, 2005
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapyDaniel M Witt, Melanie A Sadler, Roberta L Shanahan, et al.
BMJ Open|November 8, 2015
Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocolGuowei Li, Anne Holbrook, Thomas Delate, et al.
Pharmacy Practice|January 4, 2020
Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillationWhitney L Gustafson, John Saunders, Sara R Vazquez, et al.
Scientific Reports|July 6, 2023
Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillationChatree Chai-Adisaksopha, Alexandre H Watanabe, Piyameth Dilokthornsakul, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Thrombolysis|July 6, 2019
Assessing patient preferences for switching from warfarin to direct oral anticoagulantsJack N Wright, Sara R Vazquez, Kibum Kim, et al.
Thrombosis Research|November 21, 2024
Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah HealthHailey L Vandenhazel, Aaron S Wilson, Xiangyang Ye, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
"Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies, among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world data": replyAmy L Kiskaddon, Ernest K Amankwah, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2023
A scoping review of direct oral anticoagulant ambulatory management practicesJasmine S Mangrum, John A Saunders, Nathorn Chaiyakunapruk, et al.
Journal of Thrombosis and Thrombolysis|January 4, 2011
Evaluation of venous thromboembolism risk following hospitalizationSheryl J Herner, Dwight C Paulson, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2005
A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapyKandace V Anich, Daniel M Witt, Thomas Delate, et al.
Chest|May 13, 2005
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapyDaniel M Witt, Melanie A Sadler, Roberta L Shanahan, et al.
BMJ Open|November 8, 2015
Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocolGuowei Li, Anne Holbrook, Thomas Delate, et al.
Pharmacy Practice|January 4, 2020
Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillationWhitney L Gustafson, John Saunders, Sara R Vazquez, et al.
Scientific Reports|July 6, 2023
Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillationChatree Chai-Adisaksopha, Alexandre H Watanabe, Piyameth Dilokthornsakul, et al.
Pageof 17